Corporate Structure

The Biocon Group's corporate structure comprises of Biocon Limited (the Holding Company), its two subsidiaries, Syngene International Limited and Clinigene International Limited and its joint venture company Biocon Biopharmaceuticals Private Limited.

Syngene
Syngene is a 99.99% owned subsidiary of Biocon. It was incorporated on Novemvber 18, 1993. By way of a restructuring, 99.9% of the shares in Syngene held by Kiran Mazumdar Shaw, ICICI and a few other scientists were transferred to Biocon in consideration for the issue of shares by Biocon to the shareholders of Syngene on March 31, 2002. The paid-up capital of Syngene is Rs. 28,750,000.

Clinigene
Clinigene is a 100% owned subsidiary of Biocon Limited. It was incorporated on August 4, 2000 with an authorised capital of Rs 5,000,000. The paid-up capital of Clinigene is
Rs. 500,000.

Biocon Biopharmaceuticals Private Limited (BBPL)
BBPL is a Joint Venture company of Biocon in collaboration with CIMAB SA, Cuba. The equity participation by Biocon is 51%. The Joint Venture agreement was entered on February 22, 2002. The paid-up capital of BBPL is Rs. 8,800,000.